Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (MMC-1)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.
Several alternative hypotheses will be evaluated in the proposed project:
- healthier patients may self-select marijuana use;
- marijuana use may be associated with consequences that create barriers to seeking healthcare;
- marijuana use may have medicinal value that reduces the need for such care.
| Condition |
|---|
|
HIV Positive Marijuana Smoking |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study |
| Estimated Enrollment: | 150 |
| Study Start Date: | February 2012 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.
The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.
We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
HIV positive and marijuana using volunteers
Inclusion Criteria:
- Participants will be patients in the HIV clinic.
- Participants will have HIV.
- Participants will sign a single consent form.
- Participants will be marijuana users.
Exclusion Criteria:
- Participants who test negative for marijuana will be excluded.
- Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.
Contacts and Locations| Contact: Lisa Sulkowski, B.S. | (313) 993-3966 | lsulkows@med.wayne.edu |
| United States, Michigan | |
| Wayne State University (HIV clinic, Tolan Park Medical Buiding) | Recruiting |
| Detroit, Michigan, United States, 48201 | |
| Principal Investigator: Mark Greenwald, PhD | |
| Principal Investigator: | Mark Greenwald, PhD | Wayne State University |
More Information
No publications provided
| Responsible Party: | Mark Greenwald, PhD, Professor, Wayne State University |
| ClinicalTrials.gov Identifier: | NCT01536899 History of Changes |
| Other Study ID Numbers: | MMC-1, R01DA032678 |
| Study First Received: | February 16, 2012 |
| Last Updated: | May 21, 2013 |
| Health Authority: | United States: Federal Government United States: Institutional Review Board |
Keywords provided by Wayne State University:
|
HIV positive Medical Marijuana |
Additional relevant MeSH terms:
|
HIV Seropositivity HIV Infections Marijuana Abuse Marijuana Smoking Smoking Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Substance-Related Disorders Mental Disorders Habits |
ClinicalTrials.gov processed this record on May 22, 2013